Research programme: antidepressant therapies - SK Drug Development Center/Johnson & Johnson
Latest Information Update: 03 Mar 2008
At a glance
- Originator Johnson & Johnson; SK Bio-Pharmaceuticals
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Major depressive disorder
Most Recent Events
- 13 Apr 2004 Preclinical trials in Depression in South Korea (unspecified route)
- 13 Apr 2004 Preclinical trials in Depression in USA (unspecified route)